Rule, Geronimo A.
HRN: 23-06-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/20/2023
05/27/2023
IV
600mg
Q6h
Dm Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes